Z. Taskiran Et Al. , "The analysis of Interleukin-1 Receptor Antagonist and Interleukin-1 beta gene polymorphisms in Turkish FMF patients: Do they predispose to secondary amyloidosis?," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.26, no.2, pp.184, 2008
Taskiran, Z. Et Al. 2008. The analysis of Interleukin-1 Receptor Antagonist and Interleukin-1 beta gene polymorphisms in Turkish FMF patients: Do they predispose to secondary amyloidosis?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.26, no.2 , 184.
Taskiran, Z., Balci, P. B., Turel, B., Arici, M., Ozen, S., Bakkaloglu, A., ... Yilmaz, E.(2008). The analysis of Interleukin-1 Receptor Antagonist and Interleukin-1 beta gene polymorphisms in Turkish FMF patients: Do they predispose to secondary amyloidosis?. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.26, no.2, 184.
Taskiran, Z. Et Al. "The analysis of Interleukin-1 Receptor Antagonist and Interleukin-1 beta gene polymorphisms in Turkish FMF patients: Do they predispose to secondary amyloidosis?," CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.26, no.2, 184, 2008
Taskiran, Z. Et Al. "The analysis of Interleukin-1 Receptor Antagonist and Interleukin-1 beta gene polymorphisms in Turkish FMF patients: Do they predispose to secondary amyloidosis?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.26, no.2, pp.184, 2008
Taskiran, Z. Et Al. (2008) . "The analysis of Interleukin-1 Receptor Antagonist and Interleukin-1 beta gene polymorphisms in Turkish FMF patients: Do they predispose to secondary amyloidosis?." CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.26, no.2, p.184.
@article{article, author={Z. Taskiran Et Al. }, title={The analysis of Interleukin-1 Receptor Antagonist and Interleukin-1 beta gene polymorphisms in Turkish FMF patients: Do they predispose to secondary amyloidosis?}, journal={CLINICAL AND EXPERIMENTAL RHEUMATOLOGY}, year=2008, pages={184} }